Literature DB >> 32638121

Predictive factors for difficult endoscopic submucosal dissection for esophageal neoplasia including failure of en bloc resection or perforation.

Yasuaki Nagami1, Masaki Ominami2, Taishi Sakai2, Hirotsugu Maruyama2, Shusei Fukunaga2, Koji Otani2, Shuhei Hosomi2, Fumio Tanaka2, Noriko Kamata2, Koichi Taira2, Tetsuya Tanigawa2, Masatsugu Shiba2,3, Toshio Watanabe2, Yasuhiro Fujiwara2.   

Abstract

BACKGROUND: Endoscopic submucosal dissection (ESD) is accepted as the standard treatment for early-stage esophageal neoplasia. However, esophageal perforation may occur, leading to mediastinitis and pneumothorax, which occasionally require emergency surgery. Moreover, failure of en bloc resection causes local recurrence. However, studies on the predictors of such difficulties during ESD are limited. Hence, we evaluated the predictors associated with the difficulty of ESD for esophageal neoplasia including failure of en bloc resection or perforation.
METHODS: Data of 549 consecutive patients who were treated with ESD between May 2004 and March 2016 at a single institution were retrospectively studied. Exclusion criteria were the presence of metachronous esophageal neoplasia or missing data. The primary outcome was determining the predictors associated with the difficulty of ESD for esophageal neoplasia including failure of en bloc resection or perforation.
RESULTS: Altogether, 543 patients with 736 lesions were evaluated. Failure of en bloc resection occurred in 6 patients (1.1%) with 6 lesions, and perforation occurred in 11 patients (2.0%) with 11 lesions (1.5%). Multivariate logistic regression analysis showed that large lesion diameter (odds ratio [OR] 1.49; 95% confidence interval [CI] 1.21-1.84; p < 0.001) and previous chemoradiotherapy (OR 5.24; 95% CI 1.52-18.06; p = 0.009) were independent predictive factors.
CONCLUSIONS: Larger lesions and previous chemoradiotherapy for esophageal cancer increased the risk for failure of en bloc resection or perforation in patients who underwent esophageal ESD.

Entities:  

Keywords:  Difficulty; ESD; Esophageal cancer; Failure; Perforation

Year:  2020        PMID: 32638121     DOI: 10.1007/s00464-020-07777-0

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  5 in total

1.  Risk factors for the failure of endoscopic resection of gastric submucosal tumors: a long-term retrospective case-control study.

Authors:  Yuzhu Yuan; Lixin Sun; Xiaoying Zhou; Han Chen; Xinmin Si; Weifeng Zhang; Yun Wang; Bixing Ye; Nana Tang; Guoxin Zhang; Xueliang Li; Hongjie Zhang; Chunhua Jiao
Journal:  Gastric Cancer       Date:  2022-06-26       Impact factor: 7.701

2.  Propensity-score matched analysis to evaluate efficacy of endoscopic submucosal dissection for superficial esophageal cancer in gastrectomized patients.

Authors:  Yasuhiko Hamada; Kyosuke Tanaka; Masaki Katsurahara; Noriyuki Horiki; Yuhei Umeda; Yohei Ikenoyama; Hiroki Yukimoto; Masahiko Tameda; Junya Tsuboi; Reiko Yamada; Misaki Nakamura; Hayato Nakagawa
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

3.  Efficacy of lidocaine injection method for esophageal endoscopic submucosal dissection: single-center, double-blind, randomized controlled trial.

Authors:  Tetsuya Yoshizaki; Masanori Matsumoto; Tomoya Sako; Yuzo Kodama; Akihiko Okada
Journal:  Surg Endosc       Date:  2022-10-20       Impact factor: 3.453

4.  Association between Submucosal Fibrosis and Endoscopic Submucosal Dissection of Recurrent Esophageal Squamous Cell Cancers after Chemoradiotherapy.

Authors:  Tsunetaka Kato; Takuto Hikichi; Jun Nakamura; Minami Hashimoto; Ryoichiro Kobashi; Takumi Yanagita; Rei Suzuki; Mitsuru Sugimoto; Yuki Sato; Hiroki Irie; Mika Takasumi; Yuka Oka; Tadayuki Takagi; Yuko Hashimoto; Masao Kobayakawa; Hiromasa Ohira
Journal:  Cancers (Basel)       Date:  2022-09-26       Impact factor: 6.575

5.  Risk Factors for Fever After Esophageal Endoscopic Submucosal Dissection and Its Derived Technique.

Authors:  Foqiang Liao; Zhenhua Zhu; Yongkang Lai; Xiaolin Pan; Shunhua Long; Xiaojiang Zhou; Guohua Li; Yin Zhu; Youxiang Chen; Xu Shu
Journal:  Front Med (Lausanne)       Date:  2022-02-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.